News | June 25, 2024
Arkema grants technology license to Seqens to manufacture PEKK for sale in medical implantable applications
PEKK is a high-performance polymer family used in aerospace and other demanding markets
PEKK is a high-performance polymer family used in aerospace and other demanding markets
The facility was inspected from May 7 to May 17, 2024
This tie-up will have no impact on any other brands of the company
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
Approval based on CAPItello-291 results which showed this combination reduced the risk of disease progression or death by 50% vs. Faslodex alone in a biomarker-altered population
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas
This clearance is a foundational step in Roche's commitment to enable routine clinical diagnosis with its digital pathology solutions
Subscribe To Our Newsletter & Stay Updated
